Parkinson’s Disease
Author:
Burkhardt Heinrich
Publisher
Springer Vienna
Reference32 articles.
1. Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 20:1255–1263
2. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA (1996) Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334:71–76
3. Brooks DJ (2004) Safety and tolerability of COMT inhibitors. Neurology 62(Suppl 1):S39–S46
4. Chou KL, Messing S, Oakes D, Feldman PD, Breier A, Friedman JH (2005) Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments. Clin Neuropharmacol 28:215–219
5. Csoti I, Fornadi F (2008) Medikamentöse Interaktionen in der Parkinson-Therapie. NeuroGeriatrie 5:160–168